Researchers believe they could pre-emptively create vaccines and drugs to fight a wide range of viral threats - if they can get sufficient funding.

Nassim Nicholas Taleb is frustrated whenever the coronavirus crisis is referred to by the term he coined for an unpredictable, rare catastrophe.

Anders Tegnell talks to Nature about the nation's 'trust-based' approach to tackling the pandemic.

There will be no quick return to our previous lives, according to nearly two dozen experts. But there is hope for managing the scourge now and in the long term.

The chancellor's rigor in collating information, her honesty in stating what is not yet known, and her composure are paying off.

The lungs are ground zero for COVID-19, but blood clots may play a surprisingly big role in severe illness.

Magical thinking hampered the ability of even some of the most seasoned infectious diseases experts to recognize the full threat.

PLOS Biology, PLOS Medicine, PLOS Computational Biology, PLOS Genetics, PLOS Neglected Tropical Diseases and PLOS Pathogens have all revised their ‘scooping’ policy to waive the novelty criteria for work submitted within six months of a similar study having been published.

Due to precautionary measures in regard to the coronavirus, the second day of this year's Open Science Conference got canceled. Luckily, the panellists Johanna Havemann, Anne-Floor Scholvinck, Daniel Spichtinger and August Wierling agreed to submit their opening statements as a blog post.

During this unprecedented global emergency, LIBER calls on European Commissioners, Member State governments, publishers and authors to urgently help libraries, universities and other educational establishments, so that they can continue supplying researchers, teachers and students with access to books, archives and other instructional materials. 

What plants can teach us about surviving a pandemic.

The goal of the ETH4D Research Challenges is to enable collaborations on project-​based research between ETH researchers, non-​academic partners and partners from the Global South to develop effective solutions for poverty reduction combining technologies, policies and a profound understanding of human behaviour.

Check out all the latest coronavirus polling we've collected.

This new normal means mountains of single-use plastic-and few places to put it but the dump.

From Iceland to Taiwan and from Germany to New Zealand, women are stepping up to show the world how to manage a messy patch for our human family.

A decade of health disinformation promoted by President Vladimir Putin of Russia has sown wide confusion, hurt major institutions and encouraged the spread of deadly illnesses.

While some libraries seek transformative agreements, others are unbundling the Big Deal: a look at licensing models and revenue pressures for publishers.

Both cities tighten control measures after cases spike, but they could soon be relaxed again.

After the fossil fuel industry spent hundreds of millions of dollars undermining climate science, it's easy to see how epidemiology came next.

Graduate students face many of the same challenges as faculty members during COVID-19 but have received fewer assurances. Top on their wish list are extended funding and time-to-degree extensions.

Singapore, Hong Kong, South Korea, and Taiwan had flattened the curve. Then travelers from the US and Europe began reimporting the virus.

She was denied access to a telescope because of her sex, but Dr. Burbidge forged ahead anyway, going on to make pathbreaking discoveries about the cosmos.

The latest volume of Einstein's papers covers the infancy of quantum mechanics and new challenges to the theory of relativity.

Richard Epstein, a professor at N.Y.U. School of Law, discusses two articles he wrote, on the Hoover Institution Web site, entitled "Coronavirus Perspective" and "Coronavirus Overreaction," and his views of the pandemic.

"Open access" was supposed to change scientific publishing. Critics worry that the model is being corrupted by big corporate publishing money anyway.

Advances in gene sequencing have allowed scientists to trace and monitor the COVID-19 pandemic faster than any previous outbreak. However, gaps in our knowledge of how coronaviruses work has made it difficult to understand what makes the new coronavirus special.

The infectious disease researcher has become the United States's most trusted coronavirus expert.

The low-tech site run by health experts collects reports of new diseases in real time. They've got a shoestring budget-and a stunning track record.

We've known about SARS-CoV-2 for only three months, but scientists can make some educated guesses about where it came from and why it's behaving in such an extreme way.